39 algorithm-development-"Multiple"-"Prof"-"UNIS"-"St" positions at University of Basel in Switzerland
Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
discovery and development through in vitro modelling of in-patient conditions in order to address antibiotic resistance, a problem of global importance. To reach this goal, AntiResist has assembled a panel of
-
at the interface of bacterial signal transduction and phage biology. Our research group at the Biozentrum is embedded in the National Centre of Competence in Research (NCCR) AntiResist. We develop and use state
-
of adaptive radiation and associated key innovations in the evolution of freshwater diatoms. By integrating morphology, physiology, genomics, transcriptomics, and computational modeling, we aim to (i) determine
-
develop new therapies for vision loss. It is a place where your expertise will be valued, your abilities challenged, and your knowledge expanded. Position Overview We are seeking a motivated Research
-
before 1800. Candidates are conversant with current historiographical developments and have developed strong methodological skills in dealing with different source corpora of African history. We expect
-
probe microscopy. Our research focuses on using single electron spins in diamond as sensors to explore magnetic phenomena at the nanoscale. This doctoral project will center around the development and
-
, networking, and career development are located in Basel. Basel provides a high standard of living and a rich and varied cultural atmosphere.
-
basic and clinical scientists to advance our understanding of health and disease and to develop pioneering therapies benefiting the lives of patients in areas of unmet need. With more than 70 research
-
to solve fundamental questions surrounding evolution and interaction between bacteria and bacteriophages. The Biozentrum provides a highly stimulating collaborative research environment with a
-
well as to develop radically new therapies for eye diseases. These therapies are urgently needed, since the prevalence of visual diseases is rising globally, and effective therapies are lacking for most of them. As